Global Veterinary Vaccines Market Report and Forecast 2024-2032

Global Veterinary Vaccines Market Outlook

The global veterinary vaccines market value was USD 10.73 billion in 2023, driven by the rising prevalence of zoonotic diseases structure across the globe. The market size is anticipated to grow at a CAGR of 6.2% during the forecast period of 2024-2032 to achieve a value of USD 18.43 billion by 2032.

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Key Trends in the Market

Veterinary vaccines are vaccines designed for animals to keep them protected from various diseases and infections. Domesticated animals and humans are in close proximity to each other which increases the chances of transfer of diseases which is why veterinary vaccines play a key role in maintaining the health of both animals and humans. 

Many serious diseases such as epizootic disease are under control because of veterinary vaccines. They play a crucial role in restraining incurable diseases from spreading, due to which there is a steady demand for veterinary vaccines globally. 

People worldwide are increasingly adopting pets, and are investing in their healthcare and immunisation which has fuelled the growth of the global veterinary vaccines market. 

Raising livestock is a significant industry, particularly in regions with high meat consumption or export of meat. In such cases, veterinary vaccines are in high demand to ensure the health of the animal before slaughter. 

Market Analysis

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Based on vaccine type, the market can be divided into livestock vaccines and companion animal vaccines, among others. Livestock vaccines are further divided into porcine vaccines, bovine vaccines, and poultry vaccines, among others, while companion animal vaccines are divided into canine vaccines, feline vaccines, and equine vaccines among others.

On the basis of route of administration, the market is divided into oral, parenteral, and others. By distributional channel, the market is segmented into veterinary hospitals and clinics, pharmacies and drug stores, and online, among others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. 

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis. The report gives a detailed analysis of the following key players in the global veterinary vaccines market covering their competitive landscape and latest developments like mergers, acquisitions, investments and expansion plans.  

• Boehringer Ingelheim International GmbH

• Elanco Animal Health Inc.

• Zoetis Services LLC

• Merck & Co., Inc.

• Ceva Santé Animale

• Phibro Animal Health Corporation

• Dechra Pharmaceuticals PLC

• Huvepharma Inc.

• Others

Market Share by Vaccine Type

With the robust meat industry and demand for animal-derived products, livestock are kept in large numbers in regions across the world. Ensuring adequate health of livestock is essential to prevent spread of disease and financial losses, due to which livestock handlers invest in veterinary vaccines. Accordingly, the livestock segment occupies a leading share of the global veterinary vaccines market. 

As the popularity of pets grow and pet owners invest more financially into the well-being and health of companion animals, the demand for companion animal vaccines is expected to witness a steady rise in the coming years. 

Market Share by Route of Administration

The parenteral route of administration of vaccines is the most common technique used, particularly for livestock. In this method, vaccines are injected directly into the skin or muscle of the animals. This process is speedy and efficient, with a leading share in the global veterinary vaccines market.

The oral route of administration is more common for companion animals and involves giving the animal vaccine either in the form of pills or suppositories that can be fed to the animal along with food. Although oral administration is less stressful for animals as compared to injections, and can also be given at home, providers need to be more careful to ensure the animal has swallowed the pill without spitting it out. 

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Competitive Landscape

Boehringer Ingelheim International GmbH is a pharmaceutical company that is completely driven by research. It was established in 1885 and is headquartered in Germany. It is known for manufacturing and exporting healthcare products for animals and humans. 

Elanco Animal Health Inc. founded in 1954 is headquartered in Indiana, United States. It is a pharmaceutical company producing medicines and a variety of vaccines for animals, including pets and animals owned by farmers. 

Zoetis Services LLC is a healthcare company for animals founded in 1952. It has its headquarter in New Jersey, United States and believes in providing the consumers with medicines, vaccines, and diagnostic products of best quality. 

Other market players include Merck & Co., Inc., Ceva Santé Animale, Phibro Animal Health Corporation, Dechra Pharmaceuticals PLC, and Huvepharma Inc., among others.

Key Highlights of the Report